JCS speaks with Tim Clark and Will Maier at ICON plc to examine the key clinical, regulatory, and commercial challenges associated with the development of therapies for the treatment of rare diseases

With 350 million people affected worldwide, rare diseases represent a major unmet medical need. There is, however, no cure for the majority
of rare diseases and many go undiagnosed. Tim Clark and Will Maier at ICON plc examine the key clinical, regulatory and commercial challenges associated with the development of therapies for the treatment of rare diseases in this compelling interview.